FDA clears Tandem Control-IQ+ AID for T1D in pregnancy
Key Questions
What is the significance of FDA clearance for Tandem Control-IQ in pregnancy?
The FDA has cleared Tandem's Control-IQ automated insulin delivery (AID) system specifically for T1D pregnancies, marking a first for glycemic management.
How does Control-IQ improve outcomes in T1D pregnancy?
The CIRCUIT study showed 12.6% improved time-in-range (TIR 63-140mg/dL), making it a game-changer for glycemic control in first pregnancies with T1D, T2D, or GDM.
Who is adopting Control-IQ for T1D pregnancy management?
Clinicians like Rachel Sood are integrating it via care teams, expanding clearance for better navigation of diabetes in pregnancy.
Automated insulin delivery FDA-indicated for T1D pregnancy; CIRCUIT 12.6% improved TIR 63-140mg/dL + clearance expansion. Rachel Sood adoption via teams; glycemic game-changer + first-preg T1/T2/GDM navigation.
Sources (2)
Updated May 6, 2026